University of Oxford study supports use of Vaxzevria as third-dose booster against Omicron

Read more

UK government to purchase additional 1.75 million courses of Molnupiravir

Read more

Serum waives AstraZeneca shot indemnity for refugee programme

Read more

Valneva says Chikungunya vaccine phase-III trial has met primary endpoint

Read more

US FDA authorises first oral antiviral to treat COVID

Read more

10th Indian Pharma Expo held in Delhi

Read more

Zydus Cadila receives tentative approval from US FDA for Pimavanserin tablets

Read more

Government approves PLI scheme to boost domestic API production: Dr Mansukh Mandaviya

Read more

Discerning the next frontier for quality excellence in Indian pharma industry

Read more

US FDA approves expanded use of Amgen’s psoriasis drug

Read more